Business Context and Reporting Period
This Form 8-K Current Report from Minerva Neurosciences, Inc. (NERV) covers events occurring on March 30, 2026, and April 2, 2026. The filing details the resignation of the Company's President, Geoffrey Race, and the appointment of James O'Connor to senior leadership roles.
Key Financial Metrics
This filing does not contain standard financial performance metrics such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on executive compensation and personnel changes.
- Severance Payment: One-time payment of £30,000.
- Legal Fee Reimbursement: Up to £15,000 plus VAT.
- Consulting Fees: £333 per hour with a minimum of 35 hours per month.
- Stock Options: All outstanding options for Mr. Race treated as fully vested as of March 31, 2026, with an exercise extension until January 1, 2030.
Material Changes
The primary material change is the departure of Geoffrey Race as President of Minerva Neurosciences, Inc. and Director of its subsidiary, Mind-NRG SARL, effective March 31, 2026. This departure was settled via a Settlement Agreement involving salary payments, pension contributions, pro-rated bonuses, and the acceleration of stock option vesting.
Outlook, Management Commentary, and Risks
Management Changes: James O'Connor was appointed as Chief Business Officer and General Counsel, effective April 21, 2026. Mr. Race will transition into a consultancy role commencing April 15, 2026, for a period of one year, subject to termination for cause or material breach.
Compensation Arrangements: The Company has entered into a Consultancy Agreement with Mr. Race. During the consulting period, he may be eligible for additional stock options at the discretion of the Compensation Committee.
Risks and Contingencies: The filing notes that the Consultancy Agreement may be terminated by the Company upon the occurrence of certain events, including gross misconduct or material breach by Mr. Race.
Investor Verification Checklist
- Verify the total financial impact of the Settlement Agreement, including the specific value of the annual salary and pro-rated bonus paid to Mr. Race.
- Confirm the number of stock options held by Mr. Race that were accelerated to full vesting.
- Review the full text of the Settlement Agreement (Exhibit 10.1) and Consultancy Agreement (Exhibit 10.2) for additional covenants or restrictions.
- Assess the strategic implications of the leadership transition from Mr. Race to Mr. O'Connor.